Bristol-Myers misses main goal of late-stage skin cancer trial
November 20, 2019 at 07:14 AM EST
Bristol-Myers Squibb Co said on Wednesday its late-stage trial testing a combination of its cancer drugs missed a main goal of preventing skin cancer from recurring in a certain group of patients.